FR2332759A1 - Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament - Google Patents

Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament

Info

Publication number
FR2332759A1
FR2332759A1 FR7536160A FR7536160A FR2332759A1 FR 2332759 A1 FR2332759 A1 FR 2332759A1 FR 7536160 A FR7536160 A FR 7536160A FR 7536160 A FR7536160 A FR 7536160A FR 2332759 A1 FR2332759 A1 FR 2332759A1
Authority
FR
France
Prior art keywords
triene
hydroxymethyl
hypophysis
antioestrogen
gona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7536160A
Other languages
English (en)
Other versions
FR2332759B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7536160A priority Critical patent/FR2332759A1/fr
Publication of FR2332759A1 publication Critical patent/FR2332759A1/fr
Application granted granted Critical
Publication of FR2332759B1 publication Critical patent/FR2332759B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7536160A 1975-11-26 1975-11-26 Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament Granted FR2332759A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7536160A FR2332759A1 (fr) 1975-11-26 1975-11-26 Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7536160A FR2332759A1 (fr) 1975-11-26 1975-11-26 Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
FR2332759A1 true FR2332759A1 (fr) 1977-06-24
FR2332759B1 FR2332759B1 (fr) 1978-07-28

Family

ID=9162925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536160A Granted FR2332759A1 (fr) 1975-11-26 1975-11-26 Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament

Country Status (1)

Country Link
FR (1) FR2332759A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320437A2 (fr) * 1987-12-07 1989-06-14 Schering Aktiengesellschaft 17-Méthylène- et 17-éthylidène-estratriènes ayant une activité oestrogénique
EP0715517A1 (fr) * 1993-06-15 1996-06-12 Pherin Corporation Steroides d'estrene utilises en tant qu'initiateurs neurochimiques de modification de la fonction hypothalamique humaine et compositions pharmaceutiques et procedes
WO2001058919A2 (fr) * 2000-02-11 2001-08-16 Sri International Synthese de steroides anti-oestrogenique et d'autres steroides therapeutiques issus de 21-hydroxy-19-norpregna-4-ene-3-one

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320437A2 (fr) * 1987-12-07 1989-06-14 Schering Aktiengesellschaft 17-Méthylène- et 17-éthylidène-estratriènes ayant une activité oestrogénique
EP0320437A3 (fr) * 1987-12-07 1991-07-31 Schering Aktiengesellschaft 17-Méthylène- et 17-éthylidène-estratriènes ayant une activité oestrogénique
EP0715517A1 (fr) * 1993-06-15 1996-06-12 Pherin Corporation Steroides d'estrene utilises en tant qu'initiateurs neurochimiques de modification de la fonction hypothalamique humaine et compositions pharmaceutiques et procedes
EP0715517A4 (fr) * 1993-06-15 2000-10-11 Pherin Corp Steroides d'estrene utilises en tant qu'initiateurs neurochimiques de modification de la fonction hypothalamique humaine et compositions pharmaceutiques et procedes
WO2001058919A2 (fr) * 2000-02-11 2001-08-16 Sri International Synthese de steroides anti-oestrogenique et d'autres steroides therapeutiques issus de 21-hydroxy-19-norpregna-4-ene-3-one
WO2001058919A3 (fr) * 2000-02-11 2002-05-02 Stanford Res Inst Int Synthese de steroides anti-oestrogenique et d'autres steroides therapeutiques issus de 21-hydroxy-19-norpregna-4-ene-3-one
US6784170B2 (en) 2000-02-11 2004-08-31 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
US7772218B2 (en) 2000-02-11 2010-08-10 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one

Also Published As

Publication number Publication date
FR2332759B1 (fr) 1978-07-28

Similar Documents

Publication Publication Date Title
GEP20033094B (en) Steroid Sulphatase Inhibitors
ES2138618T3 (es) Esteroides 17-sustituidos utiles en el tratamiento del cancer.
MY112405A (en) Method of tumer treatment.
DE69020458D1 (de) Transdermale in zwei Phasen wirkende Ausgabevorrichtung für Medikamente.
HUT74452A (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
GR3033524T3 (en) Steroids which inhibit angiogenesis.
ATE83149T1 (de) Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen.
ES2042725T3 (es) Procedimiento para preparar inhibidores de 5-alfa-estersa de esteroide.
DK16487A (da) Vacciner til oral indgift
GB2255505A (en) Use of inositolphosphates for preparing medicament
PE13197A1 (es) Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas
TR199901104T2 (xx) Farmas�tik bile�ikler.
FR2332759A1 (fr) Nouveaux derives 3-hydroxy 17-hydroxymethyl gona 1, 3, 5 (10) trienes, leur procede de preparation et leur application comme medicament
EP0588873A4 (fr) Traitement du cancer du foie.
JPS5610200A (en) Anthracycline glycoside* its manufacture and medicinal composition containing same for tumor treatment
USD149687S (en) Design fob a shoe
BRPI0416316A (pt) combinação de um inibidor da farnesil transferase com um agente anti-hormonal para o tratamento de cáncer de mama
ES8301866A1 (es) Un procedimiento para la obtencion de 2-alcohil-5-hidroxi- 1,4-naftoquinonas
USD159509S (en) Mors seat
USD149006S (en) Design fob a clock
USD156802S (en) Ornamental chain
ES2123432B1 (es) Aductos de complejos polihidroxilados de hierro trivalente con albumina soluble, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
USD165668S (en) Display figure
JPS51139634A (en) A composition for blood pressure regulation
USD149691S (en) Design fob a shoe

Legal Events

Date Code Title Description
ST Notification of lapse